• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受手术切除的高分化大肝细胞癌患者的特征与预后

Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.

作者信息

Lin Shu-Hsien, Eng Hock-Liew, Liu Yueh-Wei, Lin Chih-Che, Yong Chee-Chien, Wang Chih-Chi, Chen Chao-Long, Kuo Fang-Ying, Cheng Yu-Fan, Wang Jing-Houng, Yen Yi-Hao, Liu Ting-Ting, Li Wei-Feng, Chen Chien-Hung

机构信息

Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Am J Surg. 2022 Feb;223(2):339-345. doi: 10.1016/j.amjsurg.2021.03.065. Epub 2021 Apr 5.

DOI:10.1016/j.amjsurg.2021.03.065
PMID:33840448
Abstract

BACKGROUND

Large well-differentiated hepatocellular carcinoma (HCC) ≥ 3 cm (defined as atypical HCC) is uncommon. We evaluated the characteristics and outcomes of atypical HCC patients underwent liver resection (LR).

METHODS

This retrospective study enrolled patients who underwent LR for HCC from 2007 to 2017. Patient characteristics and overall survival (OS) were compared between patients with atypical HCC and patients with typical HCC (moderate-to-undifferentiated HCC ≥ 3 cm).

RESULTS

Among 598 patients, 51 (8.5%) had atypical HCC. Patients with atypical HCC had higher rates of non-hepatitis B or C infections (p = 0.02) and American Joint Committee on Cancer T1 pathology (p < 0.001), a lower rate of alpha-fetoprotein >20 ng/ml (p < 0.001) and a longer OS (p < 0.001) than those with typical HCC. Multivariate analysis showed that atypical HCC was associated with OS (HR = 0.50, 95% CI = 0.27-0.91, p = 0.02).

CONCLUSIONS

Patients with atypical HCC have a higher rate of non-hepatitis B or C infections and a lower rate of aggressive tumor biologic behavior. Atypical HCC is an independent predictor of OS.

摘要

背景

直径≥3cm的大的高分化肝细胞癌(HCC)(定义为非典型HCC)并不常见。我们评估了接受肝切除术(LR)的非典型HCC患者的特征和预后。

方法

这项回顾性研究纳入了2007年至2017年因HCC接受LR的患者。比较了非典型HCC患者和典型HCC(中度至低分化HCC≥3cm)患者的特征和总生存期(OS)。

结果

在598例患者中,51例(8.5%)患有非典型HCC。与典型HCC患者相比,非典型HCC患者非乙型或丙型肝炎感染率更高(p = 0.02),美国癌症联合委员会T1期病理比例更高(p < 0.001),甲胎蛋白>20 ng/ml的比例更低(p < 0.001),OS更长(p < 0.001)。多因素分析显示,非典型HCC与OS相关(HR = 0.50,95%CI = 0.27 - 0.91,p = 0.02)。

结论

非典型HCC患者非乙型或丙型肝炎感染率更高,侵袭性肿瘤生物学行为发生率更低。非典型HCC是OS的独立预测因素。

相似文献

1
Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.接受手术切除的高分化大肝细胞癌患者的特征与预后
Am J Surg. 2022 Feb;223(2):339-345. doi: 10.1016/j.amjsurg.2021.03.065. Epub 2021 Apr 5.
2
Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?不典型大细胞高分化肝细胞癌的特征:肝细胞癌的一种特殊亚型?
HPB (Oxford). 2020 Apr;22(4):545-552. doi: 10.1016/j.hpb.2019.08.012. Epub 2019 Sep 16.
3
Overall survival among patients who undergo resection does not differ significantly between T1a and T1b hepatocellular carcinoma based on the 8 American Joint Commission on Cancer.根据美国癌症联合委员会第8版,接受手术切除的T1a期和T1b期肝细胞癌患者的总生存率无显著差异。
Langenbecks Arch Surg. 2023 Apr 27;408(1):166. doi: 10.1007/s00423-023-02841-4.
4
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.东方肝胆外科医院微血管侵犯评分系统预测 R0 肝切除术后肝细胞癌伴微血管侵犯患者的预后:一项大样本、多中心研究。
Oncologist. 2019 Dec;24(12):e1476-e1488. doi: 10.1634/theoncologist.2018-0868. Epub 2019 May 28.
5
Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma.肉瘤样肝细胞癌的临床病理特征及手术结果
World J Gastroenterol. 2020 Aug 7;26(29):4327-4342. doi: 10.3748/wjg.v26.i29.4327.
6
Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.腹腔镜手术治疗肝硬化患者肝肿瘤的益处。
J Laparoendosc Adv Surg Tech A. 2018 May;28(5):553-561. doi: 10.1089/lap.2017.0584. Epub 2018 Jan 19.
7
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
8
The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.2cm 以内单发肝细胞癌长期生存预后的危险因素:高乙肝病毒感染率人群队列的倾向评分匹配分析。
Int J Surg. 2019 Dec;72:1-6. doi: 10.1016/j.ijsu.2019.10.006. Epub 2019 Oct 11.
9
Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.比较Ⅰ型和Ⅱ型门静脉癌栓肝癌患者行肝移植与肝切除术的疗效。
Yonsei Med J. 2021 Jan;62(1):29-40. doi: 10.3349/ymj.2021.62.1.29.
10
High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.高水平的细胞间黏附分子-1影响肝细胞癌患者的预后。
World J Gastroenterol. 2015 Jun 21;21(23):7254-63. doi: 10.3748/wjg.v21.i23.7254.

引用本文的文献

1
Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.乙型肝炎病毒感染患者的大的高分化肝细胞癌:钆塞酸二钠增强磁共振成像特征及预后
Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11994-3.
2
Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma.基于CT的影像组学联合甲胎蛋白(AFP)和异常凝血酶原(PIVKA-II)等实验室检查在肝细胞癌病理分级术前预测中的应用。
BMC Med Imaging. 2025 Feb 17;25(1):51. doi: 10.1186/s12880-025-01588-2.
3
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors.
肝细胞癌的宏观特征:一个未被充分利用的预后因素来源
J Hepatocell Carcinoma. 2024 Apr 6;11:707-719. doi: 10.2147/JHC.S447848. eCollection 2024.
4
Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma.基于多参数磁共振成像的肿瘤内及肿瘤周围影像组学用于预测肝细胞癌的病理分化
Insights Imaging. 2024 Mar 27;15(1):97. doi: 10.1186/s13244-024-01623-w.
5
Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.环状RNA hsa_circ_0005218通过靶向miR-31-5p/CDK1途径促进肝细胞癌的早期复发。
Heliyon. 2023 Mar 22;9(4):e14816. doi: 10.1016/j.heliyon.2023.e14816. eCollection 2023 Apr.